What does DR. RAYMAEKERS AN, OOGARTS do?

DR. RAYMAEKERS AN, OOGARTS is a healthcare practice in Alken. Private Limited, started on 21 April 2008, 1 establishment.

What is the address of DR. RAYMAEKERS AN, OOGARTS?

The registered office of DR. RAYMAEKERS AN, OOGARTS is located at Leemkuilstraat 31A, 3570 Alken.

Is DR. RAYMAEKERS AN, OOGARTS still active?

Yes. According to the CBE (29 September 2026) DR. RAYMAEKERS AN, OOGARTS is active, legal situation “Normale toestand”, started on 21 April 2008.

Is DR. RAYMAEKERS AN, OOGARTS registered on Peppol?

Yes, DR. RAYMAEKERS AN, OOGARTS is registered on the Peppol network with ID 0208:0898103994.

What is the enterprise number of DR. RAYMAEKERS AN, OOGARTS?

The enterprise number of DR. RAYMAEKERS AN, OOGARTS is BE0898103994.

When was DR. RAYMAEKERS AN, OOGARTS founded?

DR. RAYMAEKERS AN, OOGARTS was founded on 21 April 2008.

Who are the directors of DR. RAYMAEKERS AN, OOGARTS?

According to the 2025 annual accounts, the directors of DR. RAYMAEKERS AN, OOGARTS are: An Raymaekers, Maarten Uyttebroek.

Is DR. RAYMAEKERS AN, OOGARTS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 April 2008; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DR. RAYMAEKERS AN, OOGARTS make in 2025?

DR. RAYMAEKERS AN, OOGARTS posted a profit after taxes of € 235,398 in financial year 2025.

What is the revenue of DR. RAYMAEKERS AN, OOGARTS?

As a small company, DR. RAYMAEKERS AN, OOGARTS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 326,786.

DR. RAYMAEKERS AN, OOGARTS (Private Limited) - Alken

Dossier DR. RAYMAEKERS AN, OOGARTS, printed on 29 September 2026 from databakkes.be/en/0898103994/dr-raymaekers-an-oogarts. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. RAYMAEKERS AN, OOGARTS from Alken, company number BE0898103994, closed financial year 2025 with a result of € 235,398 after tax. For that financial year DR. RAYMAEKERS AN, OOGARTS recorded a gross margin of € 326,786 and equity of € 1.4 million. Compared with financial year 2024, the result moved from € 245,258 to € 235,398. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 1.4 million

▲ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 235,398

▼ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 214,100

▼ 46% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 178,656 paid out

76 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 3,104

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 4,460

▼ 69% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,848

▲ 40% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,852

▼ 94% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 329,074 Gross margin 2022: € 329,074 First fiscal year in the series	€ 394,942 Gross margin 2023: € 394,942 ▲ 20% vs 2022 (€ 329,074) Favourable step	€ 352,823 Gross margin 2024: € 352,823 ▼ 11% vs 2023 (€ 394,942) Unfavourable step	€ 326,786 Gross margin 2025: € 326,786 ▼ 7% vs 2024 (€ 352,823) Unfavourable step	▼ 7%
Profit after taxes	€ 193,310 Profit after taxes 2022: € 193,310 First fiscal year in the series	€ 274,367 Profit after taxes 2023: € 274,367 ▲ 42% vs 2022 (€ 193,310) Favourable step	€ 245,258 Profit after taxes 2024: € 245,258 ▼ 11% vs 2023 (€ 274,367) Unfavourable step	€ 235,398 Profit after taxes 2025: € 235,398 ▼ 4% vs 2024 (€ 245,258) Unfavourable step	▼ 4%
Equity	€ 1,074,384 Equity 2022: € 1,074,384 First fiscal year in the series	€ 1,221,635 Equity 2023: € 1,221,635 ▲ 14% vs 2022 (€ 1,074,384) Favourable step	€ 1,309,871 Equity 2024: € 1,309,871 ▲ 7% vs 2023 (€ 1,221,635) Favourable step	€ 1,366,614 Equity 2025: € 1,366,614 ▲ 4% vs 2024 (€ 1,309,871) Favourable step	▲ 4%
Total debts	€ 42,938 Total debts 2022: € 42,938 First fiscal year in the series	€ 72,345 Total debts 2023: € 72,345 ▲ 68% vs 2022 (€ 42,938) Unfavourable step	€ 62,504 Total debts 2024: € 62,504 ▼ 14% vs 2023 (€ 72,345) Favourable step	€ 25,967 Total debts 2025: € 25,967 ▼ 58% vs 2024 (€ 62,504) Favourable step	▼ 58%
Cash	€ 672,013 Cash 2022: € 672,013 First fiscal year in the series	€ 556,217 Cash 2023: € 556,217 ▼ 17% vs 2022 (€ 672,013) Unfavourable step	€ 398,940 Cash 2024: € 398,940 ▼ 28% vs 2023 (€ 556,217) Unfavourable step	€ 214,100 Cash 2025: € 214,100 ▼ 46% vs 2024 (€ 398,940) Unfavourable step	▼ 46%
Retained profit	€ 999,984 Retained profit 2022: € 999,984 First fiscal year in the series	€ 1,147,235 Retained profit 2023: € 1,147,235 ▲ 15% vs 2022 (€ 999,984) Favourable step	€ 1,235,471 Retained profit 2024: € 1,235,471 ▲ 8% vs 2023 (€ 1,147,235) Favourable step	€ 1,292,214 Retained profit 2025: € 1,292,214 ▲ 5% vs 2024 (€ 1,235,471) Favourable step	▲ 5%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 127,116 Dividend 2023: € 127,116 Unchanged (€ 0) Unchanged	€ 157,021 Dividend 2024: € 157,021 ▲ 24% vs 2023 (€ 127,116) Unchanged	€ 178,656 Dividend 2025: € 178,656 ▲ 14% vs 2024 (€ 157,021) Unchanged	▲ 14%
Balance sheet total	€ 1,117,322 Balance sheet total 2022: € 1,117,322 First fiscal year in the series	€ 1,293,980 Balance sheet total 2023: € 1,293,980 ▲ 16% vs 2022 (€ 1,117,322) Unchanged	€ 1,372,375 Balance sheet total 2024: € 1,372,375 ▲ 6% vs 2023 (€ 1,293,980) Unchanged	€ 1,392,581 Balance sheet total 2025: € 1,392,581 ▲ 1% vs 2024 (€ 1,372,375) Unchanged	▲ 1%

Key figures of DR. RAYMAEKERS AN, OOGARTS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. RAYMAEKERS AN, OOGARTS?

What happened at DR. RAYMAEKERS AN, OOGARTS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 235,398 (▼ 4% vs 2024). filed late Source: NBB ↗
Apr 21, 2008 New establishment in Alken. KBO
Apr 21, 2008 Start of the company according to the CBE. KBO

In short

From € 193,310 profit in 2022 to € 235,398 profit in 2025.

Paid € 423,163 in corporate taxes since 2022.

Best year ever: 2023, with € 274,367 profit.

Paid out € 462,793 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. RAYMAEKERS AN, OOGARTS? We notify you, reason included.

Follow DR. RAYMAEKERS AN, OOGARTS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

An Raymaekers Maarten Uyttebroek

DR. RAYMAEKERS AN, OOGARTS

Behind DR. RAYMAEKERS AN, OOGARTS are An Raymaekers and Maarten Uyttebroek.

See the full network in the app

Directors

According to the 2025 annual accounts

An Raymaekers

Director

Maarten Uyttebroek

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Leemkuilstraat 31A

3570 Alken

2.218.002.691

Meerdegatstraat 78 box a

3570 Alken

Active since 21 April 2008

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0898.103.994

VAT number

BE 0898.103.994

Registered office

Leemkuilstraat 31A, 3570 Alken

Names & denominations

DR. RAYMAEKERS AN, OOGARTS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

21 April 2008

Peppol

Active · Active since 26 Nov 2025

Activities · NACE

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

DR. RAYMAEKERS AN, OOGARTS

Financials

What happened to DR. RAYMAEKERS AN, OOGARTS?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions